Protalix BioTherapeutics, Inc.

PLXNYSE· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$52.7M

▼ 1.2% YoY

Net Income

-$6.6M

▼ 325.2% YoY

EPS

$-0.08

▼ 300.0% YoY

Cash

$14.7M

▼ 25.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.